Company profile for Agios Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a vir...
At Agios, our culture and values – which form the foundation of our company and differentiate us – are embodied in the Greek word Arete, the ancient ideal of excellence and fulfillment of one’s potential. Arete has several meanings, and each is applicable to our company. It is often used to describe virtue, to characterize someone as a “good person.” Our company comprises good people who are striving to achieve a virtuous goal. It also connotes a sense of driving for excellence, which speaks to how far we can push ourselves and reflects our focus on achieving “the other side of possible.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
88 Sidney Street Cambridge, MA 02139-4169
Telephone
Telephone
617-649-8600
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/19/3190791/31990/en/Agios-Announces-Topline-Results-from-RISE-UP-Phase-3-Trial-of-Mitapivat-in-Sickle-Cell-Disease.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/19/3190791/31990/en/Agios-Announces-Topline-Results-from-RISE-UP-Phase-3-Trial-of-Mitapivat-in-Sickle-Cell-Disease.html

GLOBENEWSWIRE
19 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179391/31990/en/Agios-to-Present-New-Mitapivat-Data-in-Rare-Blood-Disorders-at-67th-ASH-Annual-Meeting-and-Exposition.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177175/31990/en/Agios-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/17/3168588/31990/en/Agios-PYRUKYND-mitapivat-Receives-Positive-CHMP-Opinion-for-Adults-with-Thalassemia.html

GLOBENEWSWIRE
17 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-17/avanzanite-bioscience-s-partner-agios-announces-positive-chmp-opinion-for-pyrukynd-mitapivat-for

PHARMIWEB
17 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty